Venture • Life Science

Vulcan Capital, Bay City Capital and Brookside Equity Partners Invest In PTC Therapeutics

On September 19, 2001, family office Vulcan Capital, venture capital firm Bay City Capital and private equity firm Brookside Equity Partners invested in life science company PTC Therapeutics

Investment Context
  • This is Vulcan Capital’s 1st, Bay City Capital’s 16th and Brookside Equity Partners’ 1st transaction in the Life Science sector.
  • This is Vulcan Capital’s 2nd, Bay City Capital’s 24th and Brookside Equity Partners’ 5th transaction in the United States.
  • This is Vulcan Capital’s 1st, Bay City Capital’s 3rd and Brookside Equity Partners’ 1st transaction in New Jersey.
Investment Fate
  • PTC Therapeutics went public in 2013.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date September 19, 2001
Target PTC Therapeutics
Sector Life Science
Investor(s) Vulcan Capital
Bay City Capital
Brookside Equity Partners
Deal Type Venture

Target Company

PTC Therapeutics

South Plainfield, New Jersey, United States
PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs targeting an area of RNA biology we refer to as post-transcriptional control. PTC Therapeutics was founded in 1998 and is based in South Plainfield, New Jersey.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investors Overview 3

Investor

Vulcan Capital

Seattle, Washington, United States

Investor


Category Family Office
Founded 1986
Size Mega
Type Sector Agnostic
DESCRIPTION

Vulcan Capital is the private investment group of Vulcan Inc., the organization founded by Paul G. Allen to manage his personal and professional endeavors. Vulcan Capital looks to invest at all company stages and will consider opportunities across an array of industries. Sectors of interest include business services, consumer products, distribution and logistics, energy and natural resources, financial services and insurance, healthcare, manufacturing, media, technology, and telecom. The Firm's target investment size is $10 to $100 million. In addition to direct investing, Vulcan Capital also makes fund investments as well as invests in public securities. Vulcan Inc. was formed in 1986 and has offices in Seattle, Washington and Palo Alto, California.


Deal Context for Investor #
Overall 2 of 35
Sector: Life Science 1 of 5
Type: Venture 1 of 17
State: New Jersey 1 of 1
Country: United States 2 of 30
Year: 2001 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-09-09 Charter Communications

Stamford, Connecticut, United States

Charter Communications is a broadband communications company. Charter provides a full range of advanced broadband services, including advanced Charter Spectrum TV video entertainment programming, Charter Spectrum Internet® access, and Charter Spectrum Voice. Charter Communications was incorporated in 1993 and is based in Stamford, Connecticut.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2002-04-01 Oxygen Media

New York, New York, United States

Oxygen Media LLC is a cable television programming network and media company serving women audiences with a mixture of entertainment and information.

Buy -
Investor

Bay City Capital

San Rafael, California, United States

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.


Deal Context for Investor #
Overall 25 of 75
Sector: Life Science 16 of 54
Type: Venture 17 of 49
State: New Jersey 3 of 3
Country: United States 24 of 72
Year: 2001 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-03-07 Medarex

Princeton, New Jersey, United States

Medarex, Inc. is a developer of therapeutic products for cancer, autoimmune disease and other life-threatening and debilitating diseases.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2001-11-01 Pharmion

Boulder, Colorado, United States

Pharmion Corporation is a global oncology company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza®, a DNA demethylating agent.

Buy -
Investor

Brookside Equity Partners

Stamford, Connecticut, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1977
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Brookside Equity Partners (BEP) focuses on private equity investments, including direct control investments, majority or minority co-investments alongside other investment firms, and, on a selective basis, investments in private funds or special situations. BEP targets North American middle-market companies with revenues greater than $15 million and at least $5 million of EBITDA. Sectors of interest include manufacturing, chemicals, financial services, environmental, food, and distribution. Brookside Equity Partners was formed in 1977 and is based in Stamford, Connecticut.


Deal Context for Investor #
Overall 5 of 38
Sector: Life Science 1 of 1
Type: Venture 1 of 2
State: New Jersey 1 of 1
Country: United States 5 of 37
Year: 2001 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-03-01 AZEK

Chicago, Illinois, United States

AZEK is a manufacturer of residential and commercial building products, and is committed to accelerating the use of recyclable materials. AZEK is based in Chicago, Illinois.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2001-09-26 American Furniture Manufacturing

Ecru, Mississippi, United States

American Furniture Manufacturing is a manufacturer of promotional upholstered residential furniture sold to regional independent retailers, rent-to-own dealers and distributors nationwide. American Furniture Manufacturing is based in Ecru, Mississippi.

Buy $36M